REPL Replimune Group, Inc.
company
SEC Filings & Insider Trading Activity 2026

CIK: 1737953
Health Care
Biological Products, (No Diagnostic Substances) 34 filings
Russell 2000

Latest Replimune Group, Inc. (REPL) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on May 22, 2025, a 10-Q quarterly report filed on February 3, 2026, an 8-K current report filed on April 13, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Replimune Group, Inc. (REPL) (SEC CIK 1737953), with AI-powered section-by-section summaries updated daily.

10-Q: 24
10-K: 7
8-K: 3

Latest 2026 SEC Filing Dates

10-K Annual Report
May 22, 2025
10-Q Quarterly Report
Feb 3, 2026
8-K Current Report
Apr 13, 2026

Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4

FormFiling DatePeriodAnalysisSEC
8-K
Apr 13, 2026
10-Q
Feb 3, 2026Dec 31, 2025
8-K
Feb 3, 2026
8-K
Jan 12, 2026
10-Q
Nov 6, 2025Sep 30, 2025
10-Q
Aug 7, 2025Jun 30, 2025
10-K
May 22, 2025Mar 31, 2025
10-Q
Feb 12, 2025Dec 31, 2024
10-Q
Nov 12, 2024Sep 30, 2024
10-Q
Aug 8, 2024Jun 30, 2024
10-K
May 16, 2024Mar 31, 2024
10-Q
Feb 8, 2024Dec 31, 2023
10-Q
Nov 7, 2023Sep 30, 2023
10-Q
Aug 3, 2023Jun 30, 2023
10-K
May 18, 2023Mar 31, 2023
10-Q
Feb 9, 2023Dec 31, 2022
10-Q
Nov 3, 2022Sep 30, 2022
10-Q
Aug 4, 2022Jun 30, 2022
10-K
May 19, 2022Mar 31, 2022
10-Q
Feb 3, 2022Dec 31, 2021
10-Q
Nov 4, 2021Sep 30, 2021
10-Q
Aug 6, 2021Jun 30, 2021
10-K
May 20, 2021Mar 31, 2021
10-Q
Feb 4, 2021Dec 31, 2020
10-Q
Nov 5, 2020Sep 30, 2020

Frequently Asked Questions

What are the latest REPL SEC filings in 2026?

Replimune Group, Inc. (REPL) has filed a 10-K annual report on May 22, 2025, a 10-Q quarterly report on February 3, 2026, an 8-K current report on April 13, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did REPL file its most recent 10-K annual report?

Replimune Group, Inc. (REPL) filed its most recent 10-K annual report on May 22, 2025. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view REPL 10-Q quarterly reports?

Replimune Group, Inc. (REPL)'s most recent 10-Q quarterly report was filed on February 3, 2026. SignalX displays every REPL 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has REPL filed recently?

Replimune Group, Inc. (REPL)'s most recent 8-K was filed on April 13, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find REPL insider trading activity (Form 4)?

SignalX aggregates every REPL Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does REPL file with the SEC?

Replimune Group, Inc. (REPL) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new REPL filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Replimune Group, Inc. (REPL).

What is REPL's SEC CIK number?

Replimune Group, Inc. (REPL)'s SEC CIK (Central Index Key) number is 1737953. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1737953 to look up all REPL filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find REPL return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Replimune Group, Inc. (REPL) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.

Stay on top of Replimune Group, Inc. SEC filings

Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 34+ filings.